{"entity":{"type":"insider","cik":"0002020969","url":"/insider/0002020969","json_url":"/insider/0002020969.json","name":"Khan Najat","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2025-08-19","last":"2026-06-05","span_basis":"filed_date"},"name_variants":[{"name":"Khan Najat","source":"filing","n_filings":4,"first_seen":"2025-08-19","last_seen":"2026-06-05"}],"transactions":[{"id":5841759,"accession":"0002020969-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002020969-26-000004","line_url":"/filing/0002020969-26-000004#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0002020969","owner_name":"Khan Najat","owner_url":"/insider/0002020969","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23588.0,"shares_display":"23,588","price_per_share":3.5806,"price_display":"3.58","price_state":"stated","total_value":84459.1928,"total_display":"84,459.19","shares_owned_after":2175796.0,"shares_owned_after_display":"2,175,796","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-05","filed_date":"2026-06-05","scope":"insider"},{"id":5845350,"accession":"0001601830-26-000048","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601830-26-000048","line_url":"/filing/0001601830-26-000048#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0002020969","owner_name":"Khan Najat","owner_url":"/insider/0002020969","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28298.0,"shares_display":"28,298","price_per_share":3.3451,"price_display":"3.35","price_state":"stated","total_value":94659.6398,"total_display":"94,659.64","shares_owned_after":2262085.0,"shares_owned_after_display":"2,262,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-09","filed_date":"2026-03-11","scope":"insider"},{"id":4652778,"accession":"0001601830-25-000176","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601830-25-000176","line_url":"/filing/0001601830-25-000176#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0002020969","owner_name":"Khan Najat","owner_url":"/insider/0002020969","role":"Director, Officer (Chief R&D Commercial Officer)","officer_title":"Chief R&D Commercial Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":124403.0,"shares_display":"124,403","price_per_share":4.4098,"price_display":"4.41","price_state":"stated","total_value":548592.3494,"total_display":"548,592.35","shares_owned_after":611135.0,"shares_owned_after_display":"611,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-22","filed_date":"2025-12-29","scope":"insider"},{"id":4032476,"accession":"0001601830-25-000131","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001601830-25-000131","line_url":"/filing/0001601830-25-000131#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0002020969","owner_name":"Khan Najat","owner_url":"/insider/0002020969","role":"Director, Officer (Chief R&D Commercial Officer)","officer_title":"Chief R&D Commercial Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36599.0,"shares_display":"36,599","price_per_share":5.524,"price_display":"5.52","price_state":"stated","total_value":202172.876,"total_display":"202,172.88","shares_owned_after":668197.0,"shares_owned_after_display":"668,197","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-19","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001601830","name":"RECURSION PHARMACEUTICALS, INC.","url":"/issuer/0001601830","role":"Director, Officer (CEO and President)","n_filings":4,"first_seen":"2025-08-19","last_seen":"2026-06-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002020969","retrieved_at":"2026-08-21T00:55:12+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}